Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2013, Article ID 874197, 5 pages
http://dx.doi.org/10.1155/2013/874197
Case Report

Undiagnosed Chronic Granulomatous Disease, Burkholderia cepacia complex Pneumonia, and Acquired Hemophagocytic Lymphohistiocytosis: A Deadly Association

1Institut de Recherches Cliniques de Montréal, Université de Montréal, Montréal, QC, Canada H2W 1R7
2Département de Médecine, Université de Montréal, Montréal, QC, Canada H3T 1J4
3Département de Médecine, Hôpital Sacré Cœur, Université de Montréal, Montréal, QC, Canada H4J 1C5
4Centre de Recherche du Centre hospitalier de l’Université de Montréal, Montréal, QC, Canada H2W 1T8
5Service de Pneumologie, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada H2W 1T8

Received 28 June 2013; Accepted 24 July 2013

Academic Editors: T. Peros-Golubicic and R. Vender

Copyright © 2013 Maxime Maignan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. H. Segal, P. Veys, H. Malech, and M. J. Cowan, “Chronic granulomatous disease: lessons from a rare disorder,” Biology of Blood and Marrow Transplantation, vol. 17, no. 1, supplement, pp. S123–S131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Rieber, A. Hector, T. Kuijpers, D. Roos, and D. Hartl, “Current concepts of hyperinflammation in chronic granulomatous disease,” Clinical and Developmental Immunology, vol. 2012, Article ID 252460, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Winkelstein, M. C. Marino, R. B. Johnston Jr. et al., “Chronic granulomatous disease: report on a national registry of 368 patients,” Medicine, vol. 79, no. 3, pp. 155–169, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. van den Berg, E. van Koppen, A. Åhlin et al., “Chronic granulomatous disease: the European experience,” PLoS ONE, vol. 4, no. 4, Article ID e5234, 2009. View at Google Scholar
  5. P. Drevinek and E. Mahenthiralingam, “Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence,” Clinical Microbiology and Infection, vol. 16, no. 7, pp. 821–830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Horsley and A. M. Jones, “Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation,” Cochrane Database Systematic Review, vol. 10, Article ID CD009529, 2012. View at Google Scholar
  7. S. McClean and M. Callaghan, “Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention,” Journal of Medical Microbiology, vol. 58, no. 1, pp. 1–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Leitão, S. A. Sousa, A. S. Ferreira, C. G. Ramos, I. N. Silva, and L. M. Moreira, “Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species,” Applied Microbiology and Biotechnology, vol. 87, no. 1, pp. 31–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ganesan and U. S. Sajjan, “Host evasion by Burkholderia cenocepacia,” Frontiers in Cellular and Infection Microbiology, vol. 1, p. 25, 2011. View at Google Scholar
  10. E. Mahenthiralingam, T. A. Urban, and J. B. Goldberg, “The multifarious, multireplicon Burkholderia cepacia complex,” Nature Reviews Microbiology, vol. 3, no. 2, pp. 144–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Álvarez-Cardona, A. L. Rodríguez-Lozano, L. Blancas-Galicia et al., “Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease,” Journal of Clinical Immunology, vol. 32, no. 2, pp. 207–211, 2011. View at Google Scholar
  12. M. Hisano, K. Sugawara, O. Tatsuzawa, M. Kitagawa, A. Murashima, and K. Yamaguchi, “Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease,” Journal of Medical Microbiology, vol. 56, no. 5, pp. 702–705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sirinavin, C. Techasaensiri, S. Pakakasama, M. Vorachit, R. Pornkul, and R. Wacharasin, “Hemophagocytic syndrome and Burkholderia cepacia splenic microabscesses in a child with chronic granulomatous disease,” Pediatric Infectious Disease Journal, vol. 23, no. 9, pp. 882–884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Van Montfrans, E. Rudd, L. D. Van Corput et al., “Fatal hemophagocytic lymphohistiocytosis in x-linked chronic granulomatous disease associated with a perforin gene variant,” Pediatric Blood and Cancer, vol. 52, no. 4, pp. 527–529, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. K. Huynh, J. D. Plumb, G. P. Downey, M. A. Valvano, and S. Grinstein, “Inactivation of macrophage Rab7 by Burkholderia cenocepacia,” Journal of Innate Immunity, vol. 2, no. 6, pp. 522–533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Lamothe, K. K. Huynh, S. Grinstein, and M. A. Valvano, “Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles,” Cellular Microbiology, vol. 9, no. 1, pp. 40–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. E. Keith, D. W. Hynes, J. E. Sholdice, and M. A. Valvano, “Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia,” Microbiology, vol. 155, no. 4, pp. 1004–1015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. E. Janka, “Familial and acquired hemophagocytic lymphohistiocytosis,” Annual Review of Medicine, vol. 63, pp. 233–246, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Ruppert, E. C. Edmonds, M. Brook M et al., “Neuropsychological assessment in a case of adult-onset hemophagocytic lymphohistiocytosis (HLH),” The Clinical Neuropsychologist, vol. 26, no. 6, pp. 1038–1052, 2012. View at Google Scholar
  20. K. Deiva, N. Mahlaoui, F. Beaudonnet et al., “CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis,” Neurology, vol. 78, no. 15, pp. 1150–1156, 2012. View at Google Scholar
  21. L. Chiapparini, G. Uziel, C. Vallinoto et al., “Hemophagocytic lymphohistiocytosis with neurological presentation: MRI findings and a nearly miss diagnosis,” Neurological Sciences, vol. 32, no. 3, pp. 473–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-I. Henter, A. Horne, M. Aricó et al., “HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis,” Pediatric Blood and Cancer, vol. 48, no. 2, pp. 124–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. B. H. Segal, M. J. Grimm, A. N. H. Khan et al., “Regulation of innate immunity by NADPH oxidase,” Free Radical Biology and Medicine, vol. 53, no. 1, pp. 72–80, 2012. View at Google Scholar
  24. M. D. Kraaij, N. D. L. Savage, S. W. Van Der Kooij et al., “Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 41, pp. 17686–17691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Ishii, S. Ohga, S. Imashuku et al., “Nationwide survey of hemophagocytic lymphohistiocytosis in Japan,” International Journal of Hematology, vol. 86, no. 1, pp. 58–65, 2007. View at Publisher · View at Google Scholar · View at Scopus